E2006: Phase II data

The double-blind, U.S. Phase II Study 201 in 291 patients with chronic insomnia showed that all doses of oral E2006

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE